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Aim. To research the impact of agmatine on the redistribution of actin fractions, which are 
represented by cytoskeletal actin filaments, short actin filaments of the plasma membrane 
skeleton and actin monomers (G-actin) in rat leukocytes under experimental diabetes mellitus 
(EDM). Methods. Leukocytes were lyzed in Triton X-100 and subjected to centrifugation to 
obtain cytoskeletal actin filaments, short actin filaments and actin monomers, which were 
separated in SDS-PAАG, followed by the immunoblot analysis of anti-actin antibodies. Results. 
Under EDM, an intensification of the process of short actin filament depolymerization and an 
increase in the G-actin content were observed in leukocytes activated by sialospecific wheat 
germ lectin (WGA). Against a background of agmatine administration, the response dynamics 
to the WGA-stimulating effect was characterized by an increase in actin polymerization in the 
fraction of cytoskeletal filaments already after 0.5 min exposure to lectin, an exceptionally 
rapid depolymerization process after 1 min of the lectin treatment, and return to the initial 
indices after 3 min exposure to lectin. Conclusions. In leukocytes of animals with EDM against 
a background of agmatine administration, the transduction of WGA-induced signal through 
sialoglycoconjugates causes the actin redistribution. It indicates that this polyamine helps to 
restore and maintain a functional response of leukocytes to the activation signals.
K e y w o r d s: actin, leukocytes, agmatine, experimental diabetes mellitus.
Introduction
The experimental studies on leukocytes in the 
case of diabetes mellitus demonstrate signifi-
cant violations of the morphofunctional state 
of the blood cells. The reduction of chemo-
taxis capacity, phagocytic activity of leuko-
cytes, the dysfunction of adhesion, aggregation 
and migration abilities of these cells correlate 
with the level of hyperglycemia of peripheral 
blood. In turn, the morphofunctional state of 
leukocytes is addicted to the complex interac-
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tion among proteins of the membrane, the 
cytoskeleton and the network of intracellular 
signaling [1–3].
The actin cytoskeleton is a dynamic system 
involved in the adhesion and migration of 
leukocytes [4]. The process of leukocyte 
transfer from the peripheral blood into the 
subendotelium is triggered by the molecules 
of adhesion [5]. The formation of stable adhe-
sion structures as a result of actin polymeriza-
tion leads to the formation of actin сomet 
tails, which are associated with integrins at 
the front end of leukocytes and induce β1-
integrin clustering, causing the formation an 
actin rafts on the cell surface in the area of 
lamelopodia and filopodia [6]. Lamelopodia 
contain a highly dense and extensive network 
of actin filaments, which are orientated from 
the sharp ends (positively charged) to the 
edge of the cell. The polymerization of actin 
generates the force that pushes the membrane 
forward, creating preconditions for new adhe-
sion contacts of leukocytes with the endothe-
lium involving filopodia [7]. Filopodia are 
made of densely staffed parallel filaments of 
actin (10 or more), the sharp ends of which 
are directed towards the membrane. The 
grouping of actin filaments is mediated by 
fascin, a binding protein. The polarized nature 
of actin filaments allows motor proteins to 
actively transport monomers of actin to the 
ends of filopodia, thus increasing the local 
actin polymerization [8]. The mechanism for 
increasing the level of polymerized actin 
(F-actin) involves an increase in the pool of 
actin monomers of globular actin (G-actin), 
which is required for the polymerization of 
new actin filaments, or may be caused by 
increased affinity of already existing filaments 
of F-actin to G-actin. Free negatively charged 
ends of actin filaments (where the lengthening 
of actin filaments occurs) are developed in 
several ways: by removing cap proteins, 
which in the attached position at growing 
ends of actin block the process of polymeriza-
tion; by depolymerizing actin fragments ow-
ing to the disconnection of non-covalent 
bonds between actin monomers within actin 
filaments, which leads to the formation of 
shorter filaments with negatively charged free 
ends; by producing actin oligomers de 
novo [9].
The reorganization of the cytoskeleton oc-
curs when Ca2+-dependent signaling cascades, 
involving Src family kinases and low-molec-
ular GTFases, are activated [10]. GTFases of 
Rap1 family perform the activation of PI-3'-
kinase, which is required for the Rap1-
dependent activation of Rac (a member of 
small GTFase of the Rho family), through 
Vav2, and it is Rac that directly affects the 
organization of actin cytoskeleton [11]. PI-3'-
kinase enzyme plays a key role not only in the 
activation of adhesion molecules, but also in 
chemokine-induced cell adhesion and cell po-
larization [12]. In contrast, the relationship 
between L-selectins, CD44, CD43, ICAM-
1–3 and the cytoskeleton is performed through 
ezrin / radixin / moesin (ERM) protein family. 
Proteins of ERM family have both membrane 
and actin-binding domains, which enable their 
function as linkers between membrane proteins 
and the actin cytoskeleton [13]. Leukocytic 
adhesion molecules (selectin, LFA-1, VLA-4, 
ICAM-1) also interact with cytoskeletal pro-
teins using cytoplasmic actin-binding proteins 
(ABPS: actinin, paxillin, vinculin and tallinn), 
which activate Arp2/3 complex triggering the 
405
The dynamics of actin filament polymerization in activated leukocytes under experimental diabetes mellitus
actin polymerization [9]. Arp2/3 complex is a 
matrix where new actin filaments are formed, 
in addition, the complex joins in the middle of 
actin filaments and promotes their bran-
ching [14]. Actin filaments in this case are 
formed at an angle of 70° to previously formed 
actin filaments. Those filaments push the mem-
brane forward from the side of their growth 
(from leader (growing) ends). As a result of 
ATP hydrolysis, the macroergic phosphate 
necessary for the polymerization of new actin 
filaments and actin filaments at the lagging 
end, involving ADP/kofilin complex in the 
lamel region, experiences depolymeriza-
tion [15]. Thus the transfer of leukocytes is 
dynamic and multistage cascade process re-
quiring the activation of various adhesion mol-
ecules and signalling pathways, as well as the 
restructuring of actin cytoskeleton [9]. 
Therefore, the study on mechanisms of the 
actin polymerization-depolymerization is es-
sential for understanding the migratory abili-
ties and functional activity of leukocytes under 
diabetes.
It has been previously stated [16] that in 
animal leukocytes under experimental diabetes 
mellitus (EDM) the total content of actin is 
reduced, whereas actin polymerization is in-
tensified in the membrane skeleton filaments. 
Agmatine administration to animals with EDM 
increases both the total content of actin and 
the level of polymerized actin in the fraction 
of cytoskeletal filaments, which are caused by 
the depolymerization of short actin filaments 
of the plasma membrane skeleton. This poly-
amine either directly or indirectly affects the 
functional state of leukocytes. As an endoge-
nous ligand for the imidazole receptors (I1 / 
I2), and with less affinity with α2-adrenergic 
receptors, N-methyl-D-aspartate and serotonin 
receptors, agmatine lowers the glucose levels 
in plasma under DM [17–19]. The hypoglyce-
mic mechanism of agmatine is provided 
throught direct insulin-like effects on peri phe-
ral organs, interaction with β-cells of the pan-
creatic islets leading to an increased release of 
insulin, and increased secretions of endorphins 
by adrenals owing to the activation of imi da-
zo le receptors, which cause the increased glu-
cose uptake by the cells of the body [17, 20]. 
Therefore, agmatine can be used as a thera-
peutic agent for the treatment of DM and re-
lated metabolic disorders [21].
The aim of our study was to investigate the 
effects of agmatine on the redistribution of 
actin fractions represented by cytoskeletal ac-
tin filaments, short actin filaments of the plas-
ma membrane skeleton and actin monomers 
(G-actin) in leukocytes of the control group of 
animals and rats with EDM. Since there are 
adhesion molecules and receptors on the sur-
face of leukocytes, which by their biochemical 
nature are glycoconjugates with a high level 
of sialization and interact with cytoskeletal 
proteins through the membrane structures and 
signalling proteins, the dynamics of actin re-
organization was evaluated after 0.5 min, 
1 min and 3 min of leukocyte preincubation 
with wheat germ lectin (WGA) under both 
normal and diabetic conditions. WGA lectin 
interacts with sialic acid residues that are pres-
ent in terminal positions of N-linked glycopro-
teins, as well as with the residues of sialic 
acids and N-acetyl-β,D-glucosamine as part of 
O-glycans of glycoproteins and glyco li-
pids [22]. Incubating leukocytes with WGA 
lectin, we have modelled in vitro the activation 
state of leukocytes.
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Materials and Methods
Animal preparation 
The experiments were based on white outbred 
male rats weighing 150–180 g. The animals 
had free access to food and water during their 
stay under standard vivarium conditions. The 
experiments were conducted in compliance 
with the General Ethical Principles for 
Conducting Experiments on Animals adopted 
at the First National Congress on Bioethics 
(Kyiv, 2001), which agree with the provisions 
of the European Convention for the Protection 
of Vertebrate Animals used for Experimental 
and Other Scientific Purposes (Strasbourg, 
1985). The animals were divided into four 
groups: (1) control, (2) control + agmatine, (3) 
experimental diabetes mellitus (EDM), and (4) 
EDM + agmatine. EDM was induced by the 
intraperitoneal administration of 6 mg strep-
tozotocin (Sigma, United States) per 100 g of 
body mass, dissolved in 10 mM citrate buffer 
(pH 5.5). The development of diabetes was 
controlled by the blood glucose level deter-
mined 72 h after administering streptozotocin. 
Animals with a glucose level above 14 mM 
were considered eligible for experiments. 
Starting from the third day from the moment 
of inducing diabetes, the animals from the 
second and fourth groups were intramuscu-
larly administered agmatine (Sigma, United 
States) at a concentration of 20 g/kg body 
weight for 14 days, while the animals from the 
first and third groups were intramuscularly 
administered saline solution for 14 days.
Blood collection
Blood was collected after light anesthesia with 
diethylether. Heparin was added beforehand 
to prevent coagulation (the end point heparin: 
whole blood dilution = 1 : 100).
Isolation of blood leukocytes
Leukocytes were isolated from blood by cen-
trifugation in gradient of ficolltriombrast den-
sity (r = 1.076–1.078). Afterwards, the cells 
were washed twice in phosphate buffered sa-
line (PBS: (137 mM NaCl, 2.7 mM KCl, 
10 mM Na2HPO4 × 7H2O,1.8 mM KH2PO4, 
pH 7.4)). Cell viability was controlled by try-
panblue (0.1 % w/v solution) exclusion test.
Cell activation
Cells (1.5 ∙ 106) were preincubated for 0.5, 1 
or 3 min at 37 °C with WGA lectin (Lectinotest 
Laboratory, Lviv, Ukraine) in the final concen-
tration of 32 mg/ml. Then cells were washed 
with PBS+ (137 mM NaCl, 2.7 mM KCl, 
10 mM Na2HPO4 × 7H2O, 1.8 mM KH2PO4, 
1 mM CaCl2, 0.5 mM MgCl2 × 6H2O, рН 7.5).
Fractionation of actin cytoskeleton
Cells (1.5 ∙ 106) were lysed in 250 ml of the 
buffer composed of 0.5% Triton X-100, 
100 mM KCl, 5 mM MgCl2, 2 mM EGTA, 
25 mM Tris, pH 7.5 and a protease inhibitor 
cocktail (“Sigma”, USA) to separate cytoske-
le tal actin filaments from solubilized actin 
[23]. After 10 min (4 °C), cell lysates were 
centrifuged for 10 min at 10 000 g (Fig. 1). 
The yielded pallet contained long cytoskeletal 
actin filaments, whereas the supernatant con-
tained short actin filaments and actin mono-
mers. After withdrawing 10 ml samples of 
supernatant for SDS–PAGE analysis, the su-
pernatants were subjected to high-speed cen-
trifugation (1 h, 100 000 g, Fig. 1) to separate 
actin monomers (supernatant) and plasma 
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membrane skeleton (pellet). The pellet was 
dissolved in 30 ml of 8 M urea and analyzed 
by SDS–PAGE. To quantify actin in isolated 
fractions, equal volume of each fraction was 
applied onto a gel [23]. After immunoblotting 
with an anti-actin antibody, actin bands were 
Fig. 1. The immunoblot analysis of dif fe-
rent actin fractions in leukocytes of heal thy 
rats, rats with experimental diabetes melli-
tus (EDM) and after agmatine admi ni stra-
tion. The scheme for frac tio nating lysates 
obtained after cell lysis through 0.5 % Tri-
ton X-100 covers the process of separation 
of those fractions that contain cytoskeletal 
actin filaments, short actin filaments of the 
plasma membrane skeleton and actin mo-
no mers. To determine the level of actin, we 
carried out the immunoblot analysis of frac-
tions containing cytoskeletal actin fila-
ments, short actin filaments and actin mo-
no mers: А – fraction from leukocytes acti-
vated for 0.5 min. with wheat germ lectin 
(WGA) and immunoblotted for actin ; B – 
fraction from leukocytes activated for 
1 min. with WGA and immunoblotted for 
actin; С – fraction from leukocytes activa-
ted for 3 min. with WGA and immunoblot-
ted for actin. Equal volume of each fraction 
was applied onto the gel. Proteins from 
1.5 × 106 cells were loaded per lane.
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analyzed densitometrically using Gelpro32. 
The actin content of each fraction at different 
time-points of WGA activation was expressed 
as a percentage of the total actin amount. 
Immunoblotting
The lysates as well as cellular fractions were 
subjected to SDS–PAGE, transferred onto ni-
trocellulose sheets and immunoblotted essen-
tially as described [24]. The membranes were 
probed with mouse IgG anti-actin antibody 
(MP Biomedicals, OH) followed by anti-mouse 
IgG-peroxidase (Sheep anti-Mouse Ig 
Antibody, (H+L) HRP conjugate, Millipore, 
USA). The immunoreactive bands visualized 
by chemiluminescence (Pierce, IL) were ana-
lyzed densitometrically using Gelpro32.
Data analysis
The significance of differences between groups 
was calculated using Student’s t-test. P < 0.05 
was considered to be statistically significant.
Results and Discussion
The comparative analysis of actin fraction 
redistribution (represented by cytoskeletal 
filaments, short actin filaments of the plasma 
membrane skeleton and actin monomers 
(Fig. 1A–C)) was performed on the basis of 
immunoblot densitometric analysis using anti-
actin antibodies. In the cells of the control 
group, those three actin forms amounted to 
72 ± 7, 9 ± 2, and 20 ± 3 % respectively 
(Fig. 2).
After 0.5 min of stimulation by WGA lectin, 
the percentage of polymerized actin repre-
sented by cytoskeletal filaments decreased by 
18%, whereas the content of the short actin 
filament increased by 20 % in leukocytes of 
the control group (Fig. 2). After 1 min of WGA 
lectin exposure, we observed exactly the op-
posite effect: the fraction of cytoskeletal fila-
ments increased up to 70 %, whereas short 
actin filaments accounted for only 9 % of po-
lymerized actin. The level of actin monomers 
in leukocytes after 0.5 and 1 min exposure to 
lectin did not undergo any significant changes. 
In 3 min after WGA lectin exposure, F-actin 
fraction of short actin filaments of leukocytes 
increased from 9 % to 15 %, which correlated 
with a decrease in the content of G-actin 
against a background of unchanged levels of 
cytoskeletal actin filaments. The acquired data 
indicate that in the control group of animals 
the process of actin polymerization under leu-
kocyte activation by preincubation with WGA 
lectin for 0.5 min is intensified in the fraction 
of short actin filaments, and in 1 min – in the 
cytoskeletal filaments (Fig. 2). Such dynamics 
of actin polymerization in leukocytes of the 
control group apparently corresponds to the 
activation of those blood cells under stimula-
tory factors [25, 26]. 
Analyzing the redistribution of polymerized 
actin fractions, i.e. cytoskeletal actin filaments 
and short actin filaments in the initial state 
(Fig. 2, 0 min without WGA exposure), it was 
revealed that there is a decrease in the number 
of cytoskeletal actin filaments and an increase 
in short actin filaments of plasma membrane 
skeleton in leukocytes of diabetic animals 
compared with the control group in similar 
conditions (Fig. 2).
In 0.5 min of the WGA lectin stimulation, 
the leukocytes of diabetic animals contained 
66 ± 5 % of actin in the cytoskeletal filament 
fraction, 25 ± 2 % in short actin filaments, and 
9 ± 1 % accounted for actin monomers (Fig. 2). 
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The obtained results indicate that under EDM 
the stimulation with WGA lectin leads to the 
intensification of actin polymerization process 
in the fraction of leukocyte cytoskeletal fila-
ments due to the depolymerization of short 
actin filaments. The content of actin monomers 
Legends:  cytoskeletal actin filaments,  shot actin filaments,  actin monomers
Fig. 2. Redistribution dynamics of actin fractions in lysates of leukocytes containing cytoskeletal actin filaments, short 
actin filaments and actin monomers at rest (0 min) and in an activation state (after preincubation with WGA lectin for 
thirty seconds, one minute and three minutes): A – control; B – experimental diabetes mellitus (EDM); C – control 
against a background of agmatine administration; D – experimental diabetes mellitus against a background of agma-
tine administration. The data were obtained by immunoblot densitometry (Fig. 1A–C). The actin content of each 
fraction at different time-points of WGA stimulation was expressed as a percentage of the total actin amount. The data 
are presented as the mean ± standard mean error of five experiments: * Significantly different from unstimulated cells 
(0 min) at P < 0.05.
410
I. V. Brodyak, I. I. Bila, N. O. Sybirna
under such conditions did not change (Fig. 2). 
Although the level of F-actin fraction of cyto-
skeletal filaments did not undergo significant 
changes in leukocytes under EDM after 1 and 
3 min of WGA lectin exposure, the process of 
actin depolymerization (represented by actin 
of short filaments) accelerated, thus increasing 
the content of actin monomers up to 30 % 
after 3 min of WGA lectin exposure (Fig. 2).
After cell activation, there is a rapid and 
short-term increase in F-actin, which correlates 
with a decrease in the content of G-actin [27]. 
However, under EDM the opposite processes 
of intensified depolymerization of short actin 
filaments and increased contents of G-actin 
take place in leukocytes activated by WGA 
lectin. During the activation of leukocytes, 
short actin filaments are involved in changing 
the morphology and functional capacity of the 
cells, whereas the reduction of their content in 
leukocytes under diabetes mellitus clearly 
causes the impairment of all those functions. 
Such changes may be a result of the distur-
bances of transmembrane and intracellular 
signaling through sialoglycoconjugates of leu-
kocytes, the number and structural organiza-
tion of oligosaccharide chains of which are 
changed under EDM [28]. 
The results are consistent with our earlier 
research [29], which revealed that under type 
1 DM the PI-3'-kinase signaling pathway, 
which in fact causes the delay of WGA-
stimulating signal transduction, in blood leu-
kocytes is misaligned and slowed. PI-3'-kinase 
signaling pathway is involved in cellular re-
sponse to external stimuli by regulating the 
activity of proteins of the cytoskeleton [14] 
and forming stress fibrils, lamellipodia and 
filopodia of leukocytes [30, 31]. Changes in 
the level of actin polymerization-depolymer-
ization in leukocytes under EDM may indicate 
a breach in systems of activation, adhesion and 
phagocytosis, as well as manifestation of cy-
totoxicity, because the actin cytoskeleton of 
leukocytes is continually reorganized, being a 
dynamic system that determines the morpho-
logical changes in the cell [32, 33].
After agmatine administration, actin frac-
tions in leukocytes were distributed as follows 
in the control group of rats: 72 ± 6 % in the 
fraction containing membrane filaments close-
ly associated with the cytoskeleton, 18 ± 3 % 
represented short actin filaments, and actin 
monomers accounted for 10 ± 2 % (Fig. 2). 
Thus, the administration of agmatine to the 
control group of animals leads to the reduction 
of actin monomers due to the intensification 
of actin filament polymerization in the plasma 
membrane skeleton in comparison with un-
stimulated leukocytes from the control group 
of animals (Fig. 2).
In leukocytes of the control group of ani-
mals against the background of agmatine ad-
ministration after 0.5 min of WGA lectin 
stimulation, the percentage of polymerized 
actin represented by cytoskeletal filaments and 
short actin filaments, decreased by 50 % and 
11 % respectively. Such an intensive process 
of depolymerization led to a sharp increase in 
G-actin – from 10 % in the state of inactivation 
to 72 % in the state of leukocyte activation by 
WGA lectin for thirty seconds. After 1 min 
WGA lectin exposure, we observed just the 
opposite effect – an intensive process of actin 
polymerization caused an increase in F-actin 
filaments of the cytoskeletal fraction up to 
45 %, whereas the fraction of short actin fila-
ments increased up to 20 %. The level of actin 
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monomers in leukocytes after 1 min WGA 
lectin exposure decreased twofold. In 3 min 
after WGA lectin exposure, the level of F-actin 
filaments of the leukocyte cytoskeleton 
dropped to 7 %, which correlated with an in-
crease in G-actin content up to about 80 %. 
The obtained data indicate that in the control 
group of animals the agmatine administration 
causes the formation of leukocyte response to 
activation signals after 1 min exposure to 
WGA lectin, and it terminates the process of 
actin filament cell reorganization if the cells 
are preincubated for 3 min (Fig. 2). Conse qu-
en tly, the dynamics of actin redistribution in 
this group of animals shows that major chan-
ges in activated leukocytes occur in the cyto-
skeletal filaments, correlating with the chan ges 
in actin monomers. Since the level of F-actin 
fraction of short actin filaments after 1 and 
3 min. of WGA lectin stimulating effects does 
not undergo significant changes as compared 
to the initial state of leukocytes (0 min. – with-
out WGA exposure), it can be assumed that in 
the control group of animals agmatine causes 
the cytoskeletal actin filaments polymerization 
de novo at the exposure of actin monomers at 
1 min of WGA lectin action, involving the 
activation of Arp2/3 complex [34].
If agmatine is administered to animals with 
EDM, the process of polymerization in leuko-
cytes intensifies in the fraction of cytoskeletal 
filaments and depolymerization of short actin 
filaments occurs compared to animals under 
EDM without agmatine administration (Fig. 2, 
see 0 min.). Under EDM, against a background 
of agmatine administration, the stimulating 
effect of WGA lectin exposure for 0.5 min. 
leads to the intensification of actin polymeriza-
tion process in the cytoskeletal filament frac-
tion of leukocytes due to depolymerization of 
short actin filaments and usage of actin mono-
mers (Fig. 2). After 1 min WGA lectin expo-
sure, the level of F-actin filaments of the leu-
kocyte cytoskeleton reduced by 40 %, which 
correlated with an increase in G-actin content 
up to 30 % and short actin filaments up to 20 % 
(Fig. 2). After 3 min of WGA lectin stimulation 
in leukocytes of animals with EDM against the 
background of agmatine administration, actin 
was redistributed among the three fractions in 
the following ratio – 67 ± 8, 23 ± 3 and 10 ± 1, 
reaching the level of performance in an inac-
tive state (Fig. 2, see 0 and 3 min.). 
Therefore, in leukocytes of animals with 
EDM, against the background of agmatine 
administration, the dynamics of response to 
stimulating effects of WGA lectin were cha-
rac terized by the intensification of polymeriza-
tion of cytoskeletal actin filaments already 
after 0.5 min exposure to lectin, by exceptio-
nal ly rapid depolymerization processes after 
1 min exposure to lectin, and by the return to 
the performance level in the initial state after 
3 min exposure to lectin (Fig. 2). Under those 
conditions, the WGA lectin binds to comple-
mentary glycoconjugates on the surface of 
leukocytes and lectin-induced signal transduc-
tion, which causes the reorganization of the 
actin cytoskeleton, reach actin content in each 
fraction similarly to the activated leukocytes 
of the control group of animals. The findings 
indicate that agmatine positively affects the 
functional state of the animal leukocytes under 
EDM. Perhaps the normalization of glucose 
level in animals with EDM in response to 
agmatine [35, 36] is one of the mechanisms 
for mediating those functional changes in leu-
kocytes under EDM.
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Conclusions
Based on our previous results [22, 28] and 
obtained data, we can conclude that under 
EDM the changes in the number and struc-
tural organization of sialoglycoconjugates on 
the surface of leukocytes lead to the disruption 
of WGA-induced transmembrane and intracel-
lular signaling, resulting in the enhanced de-
polymerization processes of short actin fila-
ments and an increase in the content of G-actin.
In leukocytes of the animals with EDM, 
against the background of agmatine adminis-
tration, the transduction of lectin-induced sig-
nal through sialoglycoconjugates causes a 
quantitative redistribution of actin fractions. It 
indicates that polyamine helps to restore and 
maintain the functional response of leukocytes 
to the activation signals.
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Динаміка полімеризації актинових філаментів 
в активованих лейкоцитах за умов 
експериментального цукрового діабету на фоні 
введення агматину
І. В. Бродяк, І. І. Біла, Н. О. Сибірна
Мета. Дослідити вплив агматину на перерозподіл 
фракцій актину, які представлені актиновими філамен-
тами цитоскелету, короткими актиновими філамента-
ми скелету плазматичної мембрани і мономерами ак-
тину (G-актин), у лейкоцитах щурів з експерименталь-
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ним цукровим діабетом (ЕЦД) Методи. Лейкоцити 
лізували в Тритоні Х-100 і піддавали центрифугуван-
ню, у результаті якого було отримано актинові філа-
менти цитоскелету, короткі актинові філаменти і моно-
мери актину, які розділяли в SDS-ПААГ, після чого 
проводили імуноблот аналіз із використанням анти-
актинових антитіл. Результати. За умов ЕЦД у лейко-
цитах, активованих сіалоспецифічним лектином за-
родків пшениці (WGA), спостерігається інтенсифіку-
вання процесу деполімеризації коротких актинових 
філаментів і збільшення вмісту G-актину, а на фоні 
введення агматину динаміка формування відповіді на 
WGA-стимулювальний вплив характеризувалася по-
силенням полімеризації актину у фракції філаментів 
цитоскелету вже на 0,5 хв впливу лектину, дуже стрім-
ким процесом деполімеризації на 1 хв після дії лекти-
ну та поверненням показників до рівня у вихідному 
стані у разі дії лектину впродовж 3 хв. Висновки. 
У лейкоцитах тварин з ЕЦД на фоні введення агмати-
ну трансдукція WGA-індукованого сигналу через 
сіалоглікокон’югати зумовлює перерозподіл вмісту 
актину, вказуючи на те, що даний поліамін сприяє від-
новленню і підтриманню функціональної відповіді 
лейкоцитів на активаційні сигнали.
К л юч ов і  с л ов а: актин, лейкоцити, агматин, екс-
периментальний цукровий діабет.
Динамика полимеризации актиновых 
филаментов в активированных лейкоцитах 
в условиях экспериментального сахарного 
диабета на фоне введения агматина
И. В. Бродяк, И. И. Била, Н. А. Сибирна
Цель. Исследовать влияние агматина на перераспре-
деление фракций актина, которые представлены 
актиновыми филаментами цитоскелета, короткими 
актиновыми филаментами скелета плазматической 
мембраны и мономерами актина (G-актин), в лейко-
цитах крыс с экспериментальным сахарным диабетом 
(ЭСД). Методы. Лейкоциты лизировали в Тритоне 
Х-100 и подвергали центрифугированию, в результате 
которого было получено актиновые филаменты цитос-
келета, короткие актиновые филаменты и мономеры 
актина, которые разделяли в SDS-ПААГ, после чего 
проводили иммуноблот анализ с использованием 
антиактиновых антител. Результаты. В условиях ЭСД 
в лейкоцитах, активированных сиалоспецыфическим 
лектином зародышей пшеницы (WGA), наблюдается 
интенсификация процесса деполимеризации коротких 
актиновых филаментов и увеличение содержания 
G-актина, а на фоне введения агматина динамика 
формирования ответа на WGA-стимулирующее влия-
ние характеризировалась усилением полимеризации 
актина во фракции филаментов цитоскелета уже на 0,5 
мин влияния лектина, очень стремительным процессом 
деполимеризации на 1 мин после действия лектина и 
возвращением показателей к уровню в исходном со-
стоянии в случае действия лектина в течение 3 мин. 
Выводы. В лейкоцитах животных с ЭСД на фоне 
введения агматина трансдукция WGA-индуцированого 
сигнала через сиалогликоконьюгаты приводит к пере-
распределению содержания актина, указывая на то, 
что данный полиамин способствует восстановлению 
и поддержанию функционального ответа лейкоцитов 
на активационные сигналы.
К л юч е в ы е  с л ов а: актин, лейкоциты, агматин, 
экспериментальный сахарный диабет.
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